ORO CLEAR MOUTHWASH

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

CHLORHEXIDINE GLUCONATE

から入手可能:

GERMIPHENE CORPORATION

ATCコード:

A01AB03

INN（国際名）:

CHLORHEXIDINE

投薬量:

0.12%

医薬品形態:

MOUTHWASH

構図:

CHLORHEXIDINE GLUCONATE 0.12%

投与経路:

BUCCAL

パッケージ内のユニット:

500ML/4L

処方タイプ:

Prescription

治療領域:

MISCELLANEOUS ANTI-INFECTIVES

製品概要:

Active ingredient group (AIG) number: 0107629007; AHFS:

認証ステータス:

APPROVED

承認日:

2007-02-21

製品の特徴

_ _
_Appendix E- Product Monograph Template Standard _
_Page 1 of 16_
PRODUCT MONOGRAPH
Pr ORO CLEAR
®
Chlorhexidine Gluconate Oral Rinse, 0.12% w/v House Standard
Antigingivitis Oral Rinse
Germiphene Corporation
1379 Colborne Street East, Brantford, ON N3T 5M1>
www.germiphene.com
Date of Preparation:
February 15, 2007
Date of Revision:
November 2, 2015
Submission Control No: 161506
© 2015 Germiphene Corporation
All trademarks used under license.
_ _
_Appendix E- Product Monograph Template Standard _
_Page 2 of 16_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................................
3
SUMMARY PRODUCT INFORMATION
....................................................................................
3
INDICATIONS AND CLINICAL USE
..........................................................................................
3
CONTRAINDICATIONS
...............................................................................................................
3
WARNINGS AND PRECAUTIONS
..............................................................................................
3
ADVERSE REACTIONS
................................................................................................................
4
DRUG INTERACTIONS
................................................................................................................
5
DOSAGE AND ADMINISTRATION
............................................................................................
6
OVERDOSAGE
..............................................................................................................................
7
ACTION AND CLINICAL PHARMACOLOGY
..........................................................................
7
STORAGE AND STABILITY
........................................................................................................
7
SPECIAL HANDLING INSTRUCTIONS
.....................................................................................
7
DOSAGE FORMS, COMPO